Mapping COVID-19 in India:Southern states at the forefront of new JN.1 variant  

作　　者：Rabin Debnath Arshdeep Singh Kushal Seni Anjali Sharma Viney Chawla Pooja A Chawla 

机构地区：[1]Department of Pharmaceutical Chemistry,ISF College of Pharmacy,G.T Road,Ghal Kalan,Moga,Punjab,142001,India [2]Department of Pharmaceutical Analysis,ISF College of Pharmacy,G.T Road,Ghal Kalan,Moga,Punjab,142001,India [3]University Institute of Pharmaceutical Sciences and Research,Baba Farid University of Health Sciences,Faridkot,Punjab,India

出　　处：《Asian Pacific Journal of Tropical Medicine》2024年第1期1-3,共3页亚太热带医药杂志（英文版）

摘　　要：A new variant,JN.1,stemming from the omicron subvariant BA.2.86,garnered the attention of the World Health Organization(WHO)as a"variant of interest."Despite its rapid global spread,especially in the US,Canada,France,Singapore,Sweden[1],and the UK,JN.1 is considered to pose minimal danger.Current vaccinations are believed to remain effective against it.The WHO underscores the importance of maintaining immunization records amid co-occurring respiratory illnesses,and epidemiologists recommend monitoring hospitalizations,particularly in areas with low vaccination rates.

关 键 词：CANADA MAPPING SPITE 

分 类 号：R181.3[医药卫生—流行病学] R563.1[医药卫生—公共卫生与预防医学]